Table 3.
Twelve-month demographic and clinical data of rheumatoid arthritis patients in different remission statuses
| DAS28 remission (n = 102) | Only DAS28 remission (n = 75) | DAS28 + Boolean remission (n = 27) | Not in any remission (n = 171) | |
|---|---|---|---|---|
| DAS28(4v)-CRP |
1.99 ± 0.31 |
2.08 ± 0.28 |
1.75 ± 0.27 |
3.97 ± 1.12 |
| TJC28 |
0.17 ± 0.45 |
0.17 ± 0.48 |
0.15 ± 0.36 |
4.92 ± 5.39 |
| SJC28 |
0.41 ± 1.17 |
0.53 ± 1.34 |
0.07 ± 0.27 |
4.05 ± 4.66 |
| CRP (mg/dl) |
0.53 ± 0.61 |
0.56 ± 0.71 |
0.43 ± 0.14 |
1.28 ± 2.84 |
| PGH |
2.08 ± 1.56 |
2.58 ± 1.52 |
0.7 ± 0.46 |
4.99 ± 2.39 |
| Low disease activity (%) |
100 |
100 |
100 |
28.1 |
| Responder (%) |
100 |
100 |
100 |
71.9 |
| Good response (%) |
94.1 |
92 |
100 |
24.6 |
| Moderate response (%) |
5.9 |
8 |
0 |
47.4 |
| Nonresponse (%) | 0 | 0 | 0 | 28.1 |
Data presented as mean ± standard deviation or percentage. DAS28, disease activity score based on 28-joint count; DAS28(4v)-CRP, disease activity score based on 28-joint count, C-reactive protein and patient global health; TJC28, tender joint count out of 28 joints; SJC28, swollen joint count out of 28 joints; CRP, C-reactive protein; PGH, patient global health.